[HTML][HTML] Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small …

YS Huang, JLY Chen, HM Chen, LH Yeh, JY Shih… - BMC cancer, 2021 - Springer
Background Angiogenesis assessment is important for personalized therapeutic intervention
in patients with non-small-cell lung cancer (NSCLC). This study investigated whether …

Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer

Y Du, S Zhang, T Liang, J Shang, C Guo… - Acta …, 2023 - journals.sagepub.com
Background Quantitative parameters of dynamic contrast-enhanced magnetic resonance
imaging (DCE-MRI) may have the potential to reflect angiogenesis and proliferation of …

[HTML][HTML] Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to …

L Brunese, B Greco, FR Setola… - … Medical Journal of …, 2013 - ncbi.nlm.nih.gov
Background Personalized cancer therapy remains a challenge. In this context, we attempted
to identify correlations between tumour angiogenesis, tumour metabolism and tumour cell …

Monitoring response to antiangiogenic therapy in non–small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI

AJ de Langen, V van den Boogaart… - Journal of Nuclear …, 2011 - Soc Nuclear Med
With antiangiogenic agents, tumor shrinkage may be absent, despite survival benefit. The
present study assessed the predictive value of molecular imaging for the identification of …

Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated …

H Yu-Sen, JLY Chen, C Jo-Yu… - Strahlentherapie …, 2019 - search.proquest.com
Purpose We investigated whether radiologic parameters by dynamic contrast-enhanced
(DCE) integrated magnetic resonance–positron-emission tomography (MR-PET) predicts …

[HTML][HTML] Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer

W van Elmpt, M Das, M Hüllner, H Sharifi… - Radiotherapy and …, 2013 - Elsevier
Purpose Dynamic contrast-enhanced CT (DCE-CT) quantifies vasculature properties of
tumors, whereas static FDG-PET/CT defines metabolic activity. Both imaging modalities are …

Correlation between tumor metabolism and semiquantitative perfusion magnetic resonance imaging metrics in non-small cell lung cancer

SH Lee, A Rimner, E Gelb, JO Deasy, MA Hunt… - International Journal of …, 2018 - Elsevier
Purpose To correlate semiquantitative parameters derived from dynamic contrast-enhanced
magnetic resonance imaging (DCE-MRI) and 18 F-fluorodeoxyglucose positron emission …

Contrast‐enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma

U Tateishi, M Kusumoto, H Nishihara… - … Journal of the …, 2002 - Wiley Online Library
BACKGROUND The objective of this study was to investigate the role of contrast‐enhanced
dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with …

[HTML][HTML] Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis–An animal …

M Mirus, SV Tokalov, G Wolf, J Heinold… - European Radiology …, 2017 - Springer
Background To investigate vascular-related pathophysiological characteristics of two human
lung cancers with modifiable vascularisation using MRI and CT. Methods Tumour xenografts …

[HTML][HTML] 18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer

L Li, W Zhao, X Sun, N Liu, Y Zhou, X Luan… - … lung cancer research, 2020 - ncbi.nlm.nih.gov
Background The objective of this study was to explore the benefit of 18 F-AlF-NOTA-PRGD2
positron emission tomography/computed tomography (denoted as 18 F-RGD PET/CT) …